Sonire Therapeutics

Japan
Yamanashi, Yamanashi, Japan, 160-0023

Company profile

Sonire Therapeutics company profile

SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel therapeutic modality with the goal of giving cancer patients and their families a new future.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2020-02-01, Month

Headquarters

Postal code
160-0023
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$21.9M
Last funding
Series B / $17.1M / 2022-11-30
Last equity funding
Series B / $17.1M
Investors
16
Lead investors
1
Founders
2
Articles
11

Founders and investors

Founders

Jun OkamotoTohru Satoh

Lead investors

Fast Track Initiative, Inc.

Investors

Daiwa Corporate InvestmentFFG Venture Business PartnersMitsubishi UFJ CapitalNissay CapitalSBI Investment